chr3-9734381-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001003694.2(BRPF1):c.241G>A(p.Val81Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001003694.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRPF1 | NM_001003694.2 | c.241G>A | p.Val81Ile | missense_variant | Exon 2 of 14 | ENST00000383829.7 | NP_001003694.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Intellectual developmental disorder with dysmorphic facies and ptosis Uncertain:1
The c.241G>A (p.Val81Ile) variant identified in the BRPF1 gene of this individual substitutes a well conserved Valine for Isoleucine at amino acid 81/1221 (coding exon 2/14). This variant is absent from gnomAD suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms predict this variant to be Neutral (Provean; score:0.36) and Tolerated (SIFT; score: 0.558) to the function of the canonical transcript. This variant is absent from ClinVar and to our current knowledge has not been reported in affected individuals in the literature. Given the lack of compelling evidence for its pathogenicity, the c.241G>A (p.Val81Ile) variant identified in the BRPF1 gene is reported as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at